News & Trends - Pharmaceuticals
Massive FDA layoffs spark concerns over drug and device approvals, posing uncertainty in the Australian market
Thousands of employees at the U.S. Food and Drug Administration (FDA) were abruptly terminated on April 1 as part of […]
MoreNews & Trends - MedTech & Diagnostics
Deafening political silence on private hospital crisis as insurance premiums soar by up to 12%
A 3.73% average hike in private health insurance premiums was approved by Federal Health Minister Mark Butler MP and took […]
MoreNews & Trends - Biotechnology
Local biotech kicks off phase 3 trial for lung cancer combination therapy
ASX-listed biotech company Immutep has reached a major milestone, announcing that the first patient has been successfully dosed in its […]
MoreDigital & Innovation
Australian-first digital mental health program: Success hinges on fixing critical flaws before rollout
A $135.2 million government investment into the Digital Mental Health Program will see 12 mental health services provide Australians access […]
MoreLeadership & Management
New Medicines Australia Chair critical to HTA reforms
Former MTPConnect Chair, Sue MacLeman, is taking the reins as Chair of Medicines Australia, bringing three decades of firepower in […]
MoreESG
Cardinal Health sets new benchmark in sustainability
In an era where sustainability has become a corporate buzzword, Jane Crowe, Managing Director of Cardinal Health ANZ, is pushing […]
MoreHuman Resources
Return-to-office mandates: A backward step or necessary reset?
The debate over return-to-office mandates is reigniting tensions between employers and employees, as both sides grapple with defining the future […]
MoreMedical and Science
MTAA and ARCS welcome Innovation Blueprint
The NSW Government has unveiled the NSW Innovation Blueprint 2035, a strategic plan designed to solidify the state’s position as […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
Massive FDA layoffs spark concerns over drug and device approvals, posing uncertainty in the Australian market
April 3, 2025
in News & Trends - Pharmaceuticals
Deafening political silence on private hospital crisis as insurance premiums soar by up to 12%
April 3, 2025
in News & Trends - MedTech & Diagnostics
MTAA and ARCS welcome Innovation Blueprint
April 3, 2025
in Medical and Science
Local medtech company marks rapid expansion in lung disease technology
April 2, 2025
in News & Trends - MedTech & Diagnostics
Return-to-office mandates: A backward step or necessary reset?
April 2, 2025
in Human Resources
Australia rolls out landmark RSV immunisation as vaccination rates continue to decline
April 2, 2025
in News & Trends - Pharmaceuticals
Funding to transform stroke care with real-time diagnosis
April 2, 2025
in News & Trends - MedTech & Diagnostics
HTA reforms gathering dust while patients wait: Senator Ruston slams Labor’s inaction
April 1, 2025
in News & Trends - Pharmaceuticals
TGA gives green light to Ipsen’s first-in-class PPAR in rare disease
April 1, 2025
in News & Trends - Pharmaceuticals
GSK-acquired Australian drug PBS listed in bone marrow cancer
April 1, 2025
in News & Trends - Pharmaceuticals
Labor government accused of fueling private hospitals chaos
April 1, 2025
in News & Trends - MedTech & Diagnostics
New Bill forces companies to set gender equality targets
March 31, 2025
in Human Resources
Government’s funding cut to stroke programs puts thousands of lives at risk
March 31, 2025
in News & Trends - Pharmaceuticals
Local medtech reports significant patient outcomes in nerve repair surgery
March 31, 2025
in News & Trends - MedTech & Diagnostics
Boehringer Ingelheim secures PBS listing for earlier use of SGLT-2 inhibitor in diabetes
March 31, 2025
in News & Trends - Pharmaceuticals
MacLeman warns against more delays in HTA reforms as she takes the reins as MA Board Chair
March 28, 2025
in News & Trends - Pharmaceuticals
Fast-tracked cancer drugs: Balancing accelerated approvals with evidence gaps and policy challenges
March 28, 2025
in News & Trends - Pharmaceuticals
Critical budget gaps in diabetes, pathology, and preventive health
March 28, 2025
in News & Trends - MedTech & Diagnostics
Urgent care clinics five times the cost of a GP visit: Are they worth it?
March 28, 2025
in News & Trends - Pharmaceuticals
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Massive FDA layoffs spark concerns over drug and device approvals, posing uncertainty in the Australian market
Thousands of employees at the U.S. Food and Drug Administration (FDA) were abruptly terminated on April 1 as part of […]
MoreNews & Trends - MedTech & Diagnostics
Deafening political silence on private hospital crisis as insurance premiums soar by up to 12%
A 3.73% average hike in private health insurance premiums was approved by Federal Health Minister Mark Butler MP and took […]
MoreMedical and Science
MTAA and ARCS welcome Innovation Blueprint
The NSW Government has unveiled the NSW Innovation Blueprint 2035, a strategic plan designed to solidify the state’s position as […]
MoreNews & Trends - MedTech & Diagnostics
Local medtech company marks rapid expansion in lung disease technology
ASX-listed medtech company, Cyclopharm, is making a major impact in lung disease. Its Technegas device for diagnosing COPD and asthma […]
More